Moreover, anecdotal evidence and Yellow Card reports suggest some instances of misuse, where individuals outside the licensed indications (e.g., those without obesity or diabetes) use GLP-1 agonists for cosmetic weight loss
Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
Course Highlights Discover how combining lifestyle modifications with GLP-1 receptor agonists can improve weight loss, glycemic control, and overall cardiometabolic health Examine the science behind GLP-1 receptor agonists, from their effects on insulin secretion and appetite regulation to next-generation agents like tirzepatide and orforglipron Learn best practices for patient education, dosing strategies, and interprofessional collaboration while addressing contraindications, adverse effects, and compounding warnings Introduction Obesity is a chronic and prevalent condition that impacts health, contributing to higher rates of morbidity and mortality